Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

On Jan. 4, 2021, a COVID-19 vaccine developed by AstraZeneca and Oxford University was administered for the first time, to an ...

Positive full results from the Phase III TULIP-SC trial showed the subcutaneous administration of Saphnelo demonstrated a statistically ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

US biotech BostonGene has struck a research collaboration with British pharma AstraZeneca (LSE: AZN) to explore the use of ...

Solicitor General D. John Sauer is urging the Supreme Court to deny AstraZeneca’s petition to hear the constitutionality of ...

BostonGene, the developer of an AI foundation model for tumor and immune biology, has entered a strategic collaboration with ...

AstraZeneca announces Saphnelo self-administration phase III TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity: Cam ...

London's FTSE 100 reached a record high, driven by strong performances in healthcare stocks, following AstraZeneca's ...

BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...

Berkshire Hathaway's shares have edged past its industry, backed by insurance growth, rising float, strong cash and expanding ...

AstraZeneca PLC AZN shares rallied 4.89% to £140.38 Tuesday, on what proved to be an all-around positive trading session for ...